Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 25, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Prostate cryotherapy: current status.

Chad R Ritch1, Aaron E Katz

  • 1Columbia University Medical Center, NY Presbyterian Hospital, Department of Urology, New York, NY, USA.

Current Opinion in Urology
|February 7, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bladder, Penis, and Urethral Cancers and Basic Principles of Oncology.

The Journal of urology·2026
Same author

Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trial.

BJU international·2026
Same author

Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.

The Journal of urology·2026
Same author

Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancer.

Urologic oncology·2026
Same author

Differential Cytokine Profiles in Prostate Cancer Under Treatment: Implications for Prognosis and Synergistic Therapy Design.

Cancers·2026
Same author

mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active Surveillance.

Cancers·2026
Same journal

Role and relevance of genetic testing in patients with kidney stones: a review from EAU Section of Endourology.

Current opinion in urology·2026
Same journal

Advances in evaluating and delivering nontechnical skills training: The use of simulation, robotics, artificial intelligence and virtual reality.

Current opinion in urology·2026
Same journal

Educating for a sustainable future: faculty and student perspectives and a review of environmental sustainability in medical education - an EAU endourology study.

Current opinion in urology·2026
Same journal

Shaping the future of endourology: role of education, simulation and uro-technology: a scoping review by the EAU Section of Endourology.

Current opinion in urology·2026
Same journal

A review of emerging technologies and techniques for percutaneous nephrolithotomy access.

Current opinion in urology·2026
Same journal

Artificial intelligence in kidney cancer: a review of clinical applications across the disease spectrum.

Current opinion in urology·2026
See all related articles

Cryotherapy is an effective minimally invasive treatment for low-risk prostate cancer, comparable to other methods. Newer focal cryotherapy techniques show promise for reduced side effects and good outcomes.

Area of Science:

  • Urology
  • Oncology
  • Minimally Invasive Surgery

Background:

  • Minimally invasive treatments are preferred for low-risk prostate cancer over radical therapies.
  • Advancements in cryotherapy technology are increasing its adoption.
  • Emerging long-term data are crucial for evaluating cryotherapy's efficacy.

Purpose of the Study:

  • To review contemporary data on prostate cancer cryotherapy.
  • To focus on studies utilizing the latest cryotherapy technology.
  • To assess the efficacy and safety of modern cryotherapy techniques.

Main Methods:

  • Review of contemporary studies on prostate cancer cryotherapy.
  • Analysis of data focusing on third-generation cryosystems.
  • Evaluation of biochemical recurrence, erectile dysfunction, and incontinence rates.

More Related Videos

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Related Experiment Videos

Last Updated: Jun 25, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Main Results:

  • Cryotherapy demonstrates comparable biochemical recurrence rates to other treatments for low-risk prostate cancer.
  • Third-generation cryosystems show low rates of incontinence and urethrorectal fistula.
  • Focal cryotherapy offers encouraging short-term efficacy and significantly lower erectile dysfunction rates for unifocal disease.

Conclusions:

  • Cryosurgery is a viable option for primary and salvage treatment in select prostate cancer patients.
  • Focal cryotherapy provides a minimally adverse effect profile for unilateral disease.
  • Ongoing research and multicenter databases will further elucidate optimal outcomes and treatment patterns.